Vimarsana
Biggest News Aggregation in the World

Page 8 - Breakthrough Status News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Status. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Status Today - Breaking & Trending Today

Theradaptive Secures Third FDA Breakthrough Designation for Spinal Fusion - Vimarsana News

Theradaptive Secures Third FDA Breakthrough Designation for Spinal Fusion

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Theradaptive Secures Third FDA Breakthrough Designation for Spinal Fusion - Vimarsana News

Theradaptive Secures Third FDA Breakthrough Designation for Spinal Fusion

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Carthera receives FDA Breakthrough Device Designation for SonoCloud-9 System - Vimarsana News

Carthera receives FDA Breakthrough Device Designation for SonoCloud-9 System

Breakthrough Status allows for enhanced interaction with FDA and recognizes SonoCloud system as innovative and promising approach for treatment of recurrent glioblastoma Paris, France, June 22, 2022 – Carthera, a French company that designs and develops SonoCloud, an innovative ultrasound-based medical device to tre...

Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings - Vimarsana News

Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Digital therapeutics startup Dthera Sciences was sunk by Alzheimer's drug failures, CMS reimbursement limitations - Vimarsana News

Digital therapeutics startup Dthera Sciences was sunk by Alzheimer's drug failures, CMS reimbursement limitations

(Photo by Sebastian Kaulitzki/Getty Images) Those keeping an eye on the digital therapeutics industry over the last several years likely remember the name Dthera Sciences. The startup and its CEO Ed Cox became one of the developing space's many standard bearers around 2018. During that timeframe it landed a Breakthrough Device designation from the FDA for its Alzheimer's symptoms treatment, with Cox chairing a handful of industry networking events through the following months. But despite the regulatory win and initial interest from potential partners, Dthera's momentum petered out in t...